Preferred Label : oligopeptides;

MeSH definition : Peptides composed of between two and twelve amino acids.;

MeSH synonym : Oligopeptide;

Wikipedia automatic translation : Peptide;

MeSH annotation : 2-12 amino acids (includes DIPEPTIDES, tripeptides, tetrapeptides, pentapeptides, etc.); GEN; prefer specifics; conformation: coord OLIGOPEPTIDES or specific peptide (IM) PROTEIN CONFORMATION (NIM);

Wikipedia link : https://en.wikipedia.org/wiki/Peptide;

Is substance : O;

Details


Main resources

You can consult :

Peptides composed of between two and twelve amino acids.

https://www.has-sante.fr/jcms/p_3266393/fr/kyprolis-carfilzomib-myelome-multiple
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
carfilzomib
adult
antineoplastic agents
antineoplastic combined chemotherapy protocols
multiple myeloma
dexamethasone
daratumumab
evaluation of the transparency committee
carfilzomib
oligopeptides
antibodies, monoclonal

---
https://www.has-sante.fr/jcms/p_3242183/fr/firmagon
2021
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
degarelix
Degarelix Acetate
degarelix
injections, subcutaneous
hormone antagonists
prostatic neoplasms
neoplasms, hormone-dependent
advanced hormone-dependent prostate cancer
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
oligopeptides

---
https://www.cochrane.org/fr/CD012548/PROSTATE_le-degarelix-dans-le-cancer-avance-de-la-prostate-recemment-diagnostique
2021
United Kingdom
review of literature
french abstract
oligopeptides
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
diagnosis
Prostate cancer
neoplasm, malignant
recent
prostatism, nos
prostate, nos
prostatic neoplasms
degarelix
prostate cancer
malignant neoplasm prostate

---
https://www.has-sante.fr/jcms/c_2635789/fr/kyprolis-carfilzomib-antineoplasique
2019
false
true
false
false
France
carfilzomib
multiple myeloma
Lenalidomide
dexamethasone
drug therapy, combination
adult
oligopeptides
treatment outcome
evaluation of the transparency committee
antineoplastic agents
carfilzomib
Kyprolis
oligopeptides

---
http://conseil-scientifique.public.lu/fr/publications/oncologie/degarelix-mise-a-jour-2018.html
2018
false
false
true
Luxembourg
French
injections, subcutaneous
guidelines for drug use
degarelix
degarelix
gonadotropin-releasing hormone
hormone antagonists
neoplasms, hormone-dependent
prostatic neoplasms
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
oligopeptides

---
https://www.has-sante.fr/portail/jcms/c_2825861/fr/kyprolis-carfilzomib-antineoplasique
2018
false
false
false
France
French
treatment outcome
carfilzomib
carfilzomib
orphan drug production
antineoplastic combined chemotherapy protocols
multiple myeloma
dexamethasone
antineoplastic agents
infusions, intravenous
adult
proteasome inhibitors
evaluation of the transparency committee
survival analysis
guidelines for drug use
continuity of patient care
oligopeptides

---
https://www.has-sante.fr/portail/jcms/c_2830613/fr/kyprolis-carfilzomib-antineoplasique
https://www.has-sante.fr/portail/jcms/c_2830613/fr/kyprolis
2018
false
false
false
France
French
treatment outcome
carfilzomib
carfilzomib
orphan drug production
antineoplastic combined chemotherapy protocols
multiple myeloma
dexamethasone
antineoplastic agents
infusions, intravenous
adult
proteasome inhibitors
evaluation of the transparency committee
survival analysis
guidelines for drug use
continuity of patient care
oligopeptides
thalidomide
thalidomide
Lenalidomide

---
https://www.pharmactuel.com/index.php/pharmactuel/article/view/1209
2018
false
false
false
Canada
French
journal article
treatment outcome
disease-free survival
carfilzomib
elotuzumab
daratumumab
antineoplastic agents
antineoplastic agents
ixazomib
recurrence
multiple myeloma
oligopeptides
antibodies, monoclonal, humanized
antibodies, monoclonal
boron compounds
glycine
glycine
indoles
hydroxamic acids
Panobinostat

---
Adlumiz anamorelin
Refused - This medicinal product has been refused
https://www.ema.europa.eu/medicines/human/EPAR/Adlumiz
2017
false
false
false
United Kingdom
French
English
drug evaluation
anamorelin
anamorelin hydrochloride
gait, nos
denied
anamorelin
hydrazines
oligopeptides
hydrazines
oligopeptides

---
https://www.has-sante.fr/portail/jcms/c_2810352/fr/kyprolis
2017
false
false
false
France
French
evaluation of the transparency committee
Kyprolis
carfilzomib
oligopeptides

---
Summary Basis of Decision (SBD) for Kyprolis
Carfilzomib, 60 mg, powder for solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00290
2016
false
false
false
Canada
French
English
treatment outcome
summary of product characteristics
drug approval
carfilzomib
carfilzomib
carfilzomib
antineoplastic combined chemotherapy protocols
multiple myeloma
dexamethasone
antineoplastic agents
antineoplastic agents
infusions, intravenous
adult
proteasome inhibitors
proteasome inhibitors
drug evaluation, preclinical
survival analysis
canada
Recurrent Multiple Myeloma
renal insufficiency
oligopeptides
oligopeptides
thalidomide
thalidomide
Lenalidomide

---
http://www.has-sante.fr/portail/jcms/c_2635789/fr/kyprolis
http://www.has-sante.fr/portail/jcms/c_2635789/fr/kyprolis-carfilzomib-antineoplasique
2016
false
false
false
France
French
treatment outcome
carfilzomib
carfilzomib
carfilzomib
orphan drug production
antineoplastic combined chemotherapy protocols
multiple myeloma
dexamethasone
antineoplastic agents
antineoplastic agents
infusions, intravenous
adult
proteasome inhibitors
proteasome inhibitors
evaluation of the transparency committee
survival analysis
guidelines for drug use
continuity of patient care
oligopeptides
oligopeptides
thalidomide
thalidomide
Lenalidomide

---
https://www.ema.europa.eu/medicines/human/EPAR/Kyprolis
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
carfilzomib
carfilzomib
carfilzomib
orphan drug production
antineoplastic combined chemotherapy protocols
multiple myeloma
dexamethasone
antineoplastic agents
antineoplastic agents
drug interactions
pregnancy
breast feeding
infusions, intravenous
adult
proteasome inhibitors
proteasome inhibitors
product surveillance, postmarketing
drug evaluation, preclinical
survival analysis
Carfilzomib/Dexamethasone Regimen
KRd Regimen
Carfilzomib/Daratumumab/Dexamethasone Regimen
oligopeptides
oligopeptides
thalidomide
thalidomide
Lenalidomide

---
http://www.cochrane.org/fr/CD004452
2014
false
false
false
United Kingdom
France
barusiban
atosiban
tocolytic agents
barusiban
atosiban
tocolytic agents
treatment outcome
pregnancy
meta-analysis
french abstract
obstetric labor, premature
receptors, oxytocin
oligopeptides
vasotocin
vasotocin
oligopeptides
vasotocin

---
Nous contacter.
29/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.